Jon is the inaugural Herman Chair of Primary Care Cancer Research and an NHMRC Practitioner Fellow at the University of Melbourne, an innovative role within the Victorian Comprehensive Cancer Centre (VCCC). He is also Director of the Australian Primary Care Collaborative Cancer Clinical Trials Group (PC4). He was previously Professor of General Practice and Head of the School of Primary, Aboriginal and Rural Healthcare at the University of Western Australia.
Jon moved to Australia in 2004 from the University of Cambridge and has developed a joint research programme in Australia and Cambridge on cancer and genetic medicine in primary care with CanTest Director Fiona Walter. He is a Visiting Research Fellow at Cambridge in recognition of this joint programme. Following his medical training at Cambridge and Oxford, he has had a highly successful career in academic primary care initially at Oxford, where he obtained his DPhil on cancer risk assessment tools, then at Cambridge before taking up the Chair at the University of Western Australia.
Jon’s research focuses on primary care oncology and the development and evaluation of complex interventions including computerised risk assessment and decision support systems, new screening and diagnostic technologies, symptom awareness campaigns, and the application of advances in genomic medicine in primary care. He is leading the development of Cancer Data Platform at the VCCC, which will link clinical general practice data to cancer hospital and cancer registry data. He will contribute to the CanTest research with specific focus on colorectal cancer and melanoma risk and diagnosis, and the use of big data to evaluate diagnostic tests in primary care.
Follow Jon on Twitter @ProfJonEmery
+61 4 1712 3271
University of Melbourne, AU
Screening and early diagnosis; risk assessment; genomics
- A systematic review to evaluate whether dermoscopy can be used accurately and effectively in primary care to improve the timely diagnosis of melanoma
- International comparison of FIT use across the globe in primary care symptomatic patients: A narrative view
- Establishing the diagnostic accuracy of haemoglobin in faecal immunochemical tests (FITs) and establishing a receiver operating characteristic (ROC) curve for FITs in the English primary care symptomatic population: A cohort study in the South West of England
- Establishing the diagnostic accuracy, acceptability and cost-effectiveness of haemoglobin in faecal immunochemical tests (FITs) in the English primary care symptomatic population: a cohort study in the East of England
- International dataset inventory for the CanTest collaborative
- Melanoma risk assessment and tailored prevention in general practice
- The clinical utility, feasibility and clinical utility of a genomic test to target bowel cancer screening
- The CRISP Trial: an RCT of computer decision support for risk-stratified colorectal cancer screening in primary care
- Studying the Continuum of Cancer Care through Linking Primary Data
- Rubin G, Walter F, Emery J, and de Wit N. Reimagining the diagnostic pathway for gastro-intestinal cancer. Nature Reviews Gastroenterology and Hepatology, 2018; doi:10.1038/nrgastro.2018.1